(Q39255427)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500865%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

Contribution of comorbidities and grade of bone marrow fibrosis to the prognosis of survival in patients with primary myelofibrosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500865%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500865%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Andrija Bogdanovic

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500865%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Vladan P Čokić

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500865%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Mirjana Gotic

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500865%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Maja Perunicic-Jovanovic

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500865%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Ana Vidovic

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500865%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Gradimir Jankovic

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500865%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Natasa Milic

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500865%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

6 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500865%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500865%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500865%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500865%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

869

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500865%20AND%20SRC:MED&resulttype=core&format=json

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

7 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0869-8

Pathogenesis of myelofibrosis with myeloid metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0869-8

A gain-of-function mutation of JAK2 in myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0869-8

Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0869-8

Identification of 'short-lived' and 'long-lived' patients at presentation of idiopathic myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0869-8

Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0869-8

Validation and comparison of contemporary prognostic models in primary myelofibrosis: analysis based on 334 patients from a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0869-8

Dynamic model for predicting death within 12 months in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0869-8

New and old treatment modalities in primary myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0869-8

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0869-8

Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0869-8

The European Consensus on grading of bone marrow fibrosis allows a better prognostication of patients with primary myelofibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0869-8

Prognostic importance of comorbidity in a hospital-based cancer registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0869-8

Association of comorbidities with overall survival in myelodysplastic syndrome: development of a prognostic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0869-8

Comorbidities and survival in a large cohort of patients with newly diagnosed myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0869-8

Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0869-8

A comparison of the Charlson comorbidity index derived from medical record data and administrative billing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0869-8

Grade of bone marrow fibrosis is associated with relevant hematological findings-a clinicopathological study on 865 patients with chronic idiopathic myelofibrosis

21 January 2018

1 reference

12 December 2020

Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis

1 reference

12 December 2020

Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system.

1 reference

12 December 2020

Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia

1 reference

12 December 2020

New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment

1 reference

12 December 2020

Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph(1+) chronic myelogenous leukemia: a multicenter trial

1 reference

12 December 2020

Significance of bone marrow fibrosis in multiple myeloma

1 reference

12 December 2020

European consensus on grading bone marrow fibrosis and assessment of cellularity

1 reference

12 December 2020

JAK2 inhibitors and myeloproliferative neoplasms.

1 reference

12 December 2020

Myelofibrosis with myeloid metaplasia in young individuals: disease characteristics, prognostic factors and identification of risk groups

1 reference

12 December 2020

10.1007/S12032-014-0869-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24500865%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference